Tbilisi

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Melanoma1 trial
• Multiple sclerosis1 trial

Phase

• Phase 32 trials
• Phase 11 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Sandoz3 trials

Running trials

• Active, not recruiting

  Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

  NCT06847724· Phase 3· Sandoz· Source

Closed trials

• Completed

  A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma

  NCT06153238· Phase 1· Sandoz· Source

• Completed

  A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

  NCT06159790· Phase 3· Sandoz· Source